BDBM50071619 (S)-N*1*-((S)-1-{(2R,3S)-3-[((R)-1-Methoxycarbamoyl-2-methyl-propylcarbamoyl)-methyl]-oxiranyl}-2-phenyl-ethyl)-2-[(quinoline-2-carbonyl)-amino]-succinamide::CHEMBL78312
SMILES: CONC(=O)[C@H](NC(=O)C[C@@H]1O[C@@H]1[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(C)C
InChI Key: InChIKey=AQMAERLRGBNCSB-PGPFONJOSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human immunodeficiency virus type 1 protease (Human immunodeficiency virus type 1) | BDBM50071619 ((S)-N*1*-((S)-1-{(2R,3S)-3-[((R)-1-Methoxycarbamoy...) | PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Biotech Research Institute Curated by ChEMBL | Assay Description Compound was tested for 50% irreversible inhibition of HIV-1 protease; value ranges from 10-50 | Bioorg Med Chem Lett 8: 2423-6 (1999) BindingDB Entry DOI: 10.7270/Q21V5D46 | |||||||||||
More data for this Ligand-Target Pair |